Evidence map›Paper›PMID 31248329›Full record

ArticleJournal of the American Heart Association2019

Provider-Level Variation in Smoking Cessation Assistance Provided in the Cardiology Clinics: Insights From the NCDR PINNACLE Registry.

Mayank Sardana, Yuanyuan Tang, Jared W Magnani, Ira S Ockene, Jeroan J Allison, Suzanne V Arnold, Phillip G Jones, Thomas M Maddox, Salim S Virani, David D McManus

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Social determinants of atrial fibrillation.Nature reviews. Cardiology · 2021
    Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Mayank Sardana1 University of California San Francisco San Francisco CA.
Yuanyuan Tang2 Mid America Heart Institute Kansas City KS.
Jared W Magnani3 University of Pittsburgh School of Medicine Pittsburgh PA.
Ira S Ockene4 University of Massachusetts Medical School Worcester MA.
Jeroan J Allison4 University of Massachusetts Medical School Worcester MA.
Suzanne V Arnold2 Mid America Heart Institute Kansas City KS.
Phillip G Jones2 Mid America Heart Institute Kansas City KS.
Thomas M Maddox5 Washington University School of Medicine St Louis MO.
Salim S Virani6 Michael E. DeBakey Veterans Affairs Medical Center Section of Cardiovascular Research Department of Medicine Baylor College of Medicine Houston TX.
David D McManus4 University of Massachusetts Medical School Worcester MA.
Saint Luke's Health System · USUniversity of Massachusetts Chan Medical School · USMichael E. DeBakey VA Medical Center · USUniversity of California, San Francisco · USUniversity of Pittsburgh · USWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Studies show suboptimal provision of smoking cessation assistance (counseling or pharmacotherapy) for current smokers attempting to quit. We aimed to identify smoking cessation assistance patterns in US cardiology practices. Methods and Results Among 328 749 current smokers seen between January 1, 2013, and March 31, 2016, in 348 NCDR (National Cardiovascular Data Registry) PINNACLE (Practice Innovation and Clinical Excellence)-affiliated cardiology practices, we measured the rates of cessation assistance. We used multivariable hierarchical logistic regression models to determine provider-, practice-, and patient-level predictors of cessation assistance. We measured provider variation in cessation assistance using median rate ratio (the likelihood that the same patient would receive the same assistance at by any given provider; >1.2 suggests significant variation). Smoking cessation assistance was documented in only 34% of encounters. Despite adjustment of provider, practice, and patient characteristics, there was large provider-level variation in cessation assistance (median rate ratio, 6 [95% CI , 5.76-6.32]). Practice location in the South region (odds ratio [OR], 0.48 [0.37-0.63] versus West region) and rural or suburban location (OR, 0.92 [0.88-0.95] for rural; OR, 0.94 [0.91-0.97] for suburban versus urban) were associated with lower rates of cessation assistance. Similarly, older age (OR, 0.88 [0.88-0.89] per 10-year increase), diabetes mellitus (OR, 0.84 [0.82-0.87]), and atrial fibrillation (OR, 0.93 [0.91-0.96]) were associated with lower odds of receiving cessation assistance. Conclusions In a large contemporary US registry, only 1 in 3 smokers presenting for a cardiology visit received smoking cessation assistance. Our findings suggest the presence of a large deficit and largely idiosyncratic provider-level variation in the provision of smoking cessation assistance.

Indexed as

Health PersonnelAdultAgedAge FactorsAmbulatory CareAtrial FibrillationCardiologistsCardiologyCigarette SmokingCounselingDiabetes MellitusDocumentationFemaleHumansMaleMiddle AgedSmoking Cessation Agentsprimary preventionquality of careregistrysmoking

Identifiers

PMID31248329
PMCPMC6662347
OpenAlexW2955342990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.